Director: Kinga Szigeti, MD, PhD

Conducts research focused on characterizing the contribution of copy number variations to the genetic architecture of Alzheimer’s disease to develop genetic biomarkers for risk stratification; explores olfactory identification deficit as a biomarker of the disease; and uses stem cell technology to study the disease mechanism.

Director: Robert Zivadinov, MD, PhD

Works to extend the boundaries of knowledge about neurological diseases and disorders through innovative neuroimaging research techniques and the application of bioinformatics resources.

Medical Director: Michelle Hartley-McAndrew, MD

Research encompasses neurobiology of children with autism spectrum disorders; concurrent seizure disorders; epileptiform abnormalities; etiology; screening and evaluation techniques.

Director: Lawrence Wrabetz, MD

Supports basic and clinical research related to the cause, prevention and treatment of myelin-related diseases, such as Krabbe and other leukodystrophies, multiple sclerosis and hereditary neuropathies.

Director: Bianca Weinstock-Guttman, MD

Conducts research to understand mechanisms of disease progression, with a primary focus on the role of environmental factors and environmental-gene interactions. Also conducts clinical trials for new pharmacologic interventions.

Provides cutting edge MRI and PET CT imaging facilities dedicated to advancing technical, basic, and translational research.

Director: Gil I. Wolfe MD, FAAN

Conducts clinical research and clinical trials in a wide variety of neuromuscular disorders with a focus on myasthenia gravis and peripheral neuropathy, including neuropathic pain.

Director: Ralph H. Benedict, PhD

Employs behavioral psychometrics to understand how cerebral disease affects personality, cognition and psychiatric stability. Develops widely adopted tests, notably memory tests, to determine areas of cognitive impairment in multiple sclerosis, cerebral injury and disease, and other conditions.